首页> 外文期刊>Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology >External beam radiation therapy for bronchial stump recurrence of non-small-cell lung cancer after complete resection.
【24h】

External beam radiation therapy for bronchial stump recurrence of non-small-cell lung cancer after complete resection.

机译:完全切除后外照射治疗非小细胞肺癌支气管残端复发。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND PURPOSE: External beam radiation therapy (EBRT) is occasionally used in the treatment of bronchial stump recurrences after complete surgical resection in patients with non-small-cell lung cancer (NSCLC), but no prospective study exists, so far. The objective of this review is to determine effectiveness of high-dose EBRT in this disease.METHODS: A systematic review was undertaken using electronic databases, reference lists and hand searching of journals to identify potentially eligible studies. Selection criteria included studies that provided outcome after high-dose EBRT in this disease. Six retrospective studies were reviewed, including a total of 54 patients.RESULTS AND CONCLUSION: High-dose EBRT appears to be an effective treatment modality for recurrent NSCLC confined to the bronchial stump after curative resection with a median survival time of approximately 30 months and 5-year survival of approximately 30%. Although small patient numbers and unclear indications for radical versus palliative EBRT may obscure the overall conclusions, among patients with intrathoracic recurrence those with bronchial stump recurrence only do better than those with non-stump recurrence. It seems there is a dose-response effect in this patient population and a predominantly local pattern of failure, both observations having an implication for future studies. The optimal dose/fractionation pattern or treatment fields must be further investigated in the future. Identification of an unfavourable subset of patients may help optimize treatment in the future by omitting high-dose, curative RT in those patients who may be best treated with palliative RT. Prospective studies on EBRT in both bronchial stump and other post-surgical recurrences are urgently needed.
机译:背景与目的:对于非小细胞肺癌(NSCLC)患者,在完全手术切除后偶尔使用外照射疗法(EBRT)治疗支气管残端复发,但迄今为止尚无前瞻性研究。审查的目的是确定大剂量EBRT在该疾病中的有效性。方法:使用电子数据库,参考文献列表和人工搜索期刊进行了系统的审查,以鉴定可能合格的研究。选择标准包括在该疾病大剂量EBRT后提供结果的研究。结果共得出6项回顾性研究,包括54例患者。结果与结论:大剂量EBRT似乎是根治性切除术后局限在支气管残端复发性NSCLC的有效治疗方式,中位生存时间约为30个月,其中5年生存率约为30%。尽管较少的患者人数以及根治性与姑息性EBRT的适应症尚不清楚,但在胸腔内复发的患者中,支气管残端复发的患者仅比非残端复发的患者好。似乎在该患者人群中有剂量反应效应,并且主要是局部衰竭模式,这两种观察结果都对未来的研究有影响。未来必须进一步研究最佳剂量/分级模式或治疗领域。识别不良患者亚群可能会在那些可能接受姑息性RT最佳治疗的患者中省略高剂量治愈性RT,从而有助于将来优化治疗。急需对支气管残端和其他术后复发中的EBRT进行前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号